Photoreceptor degeneration and dysfunction in aging and age-related maculopathy

Ageing Research Reviews

Volumn 1, Issue 3, 2002, Pages 381-396

  Jackson, Gregory R ^a   Owsley, Cynthia ^a   Curcio, Christine A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Age related maculopathy; Cones; Dark adaptation; Photopic sensitivity; Retinoid deficiency; Rods

Indexed keywords

11 CIS RETINAL; LIPOFUSCIN;

AGING; BIOASSAY; BRUCH MEMBRANE; CELL DAMAGE; CELL DEATH; CELL DEGENERATION; DARK ADAPTATION; EYE FUNDUS; GENE MUTATION; GENETIC DISORDER; HUMAN; NIGHT VISION; NONHUMAN; PHOTOPIC VISION; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA CONE; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINA ROD; RETINOL DEFICIENCY; REVIEW; TOPOGRAPHY; VISION; ANIMAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA MACULA DEGENERATION;

AGING; ANIMALS; DARK ADAPTATION; HUMANS; MACULAR DEGENERATION; PHOTORECEPTORS, VERTEBRATE;

EID: 0036594136     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(02)00007-7     Document Type: Review

References (89)

1. Age-related Eye Disease Study, 2002. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Report No. 8. Arch. Ophthalmol. 119, 1417-1436.
2. Anderson D.H., Ozaki S., Nealon M., Neitz J., Mullins R.F., Hageman G.S., Johnson L.V. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol. 131:2001;767-781.
3. Ball K., Owsley C., Stalvey B., Roenker D.L., Graves M. Driving avoidance and functional impairment in older drivers. Accident Anal. Prevent. 30:1998;313-322.
4. Barlow, H., 1972. Dark and light adaptation: psychophysics. In: Jameson, D., Hurvich, L. (Eds.), Handbook of Sensory Physiology. Springer, New York, pp. 1-28.
5. Beatty S., Boulton M., Henson D., Koh H.-H., Murray I.J. Macular pigment and age-related macular degeneration. Br. J. Ophthalmol. 83:1999;867-877.
6. Bird A.C., Bressler N.M., Chisholm I.H., Coscas G., Davis M.D., de Jong P.T.V.M., Klaver C.C.W., Klein B.E.K., Klein R., Mitchell P., Sarks J.P., Sarks S.H., Soubrane G., Tayler H.R., Vingerling J.R. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv. Ophthalmol. 39:1995;367-374.
7. Bressler N.M., Bressler S.B. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest. Ophthalmol. Vis. Sci. 41:2000;624-628.
8. Bressler N.M., Silva J.C., Bressler S.B., Fine S.L., Green W.R. Clinicopathological correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 14:1994;130-142.
9. Bridges C., Alvarez R., Fong S. Vitamin A in human eyes: amount, distribution, and composition. Invest. Ophthalmol. Vis. Sci. 22:1982;706-714.
10. Brown B., Adams A.J., Coletta N.J., Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmol. Physiol. Opt. 6:1985;81-84.
11. Carter-Dawson L., Kuwabara T., O'Brien P., Bieri J. Structural and biochemical changes in vitamin A-deficient rat retinas. Invest. Ophthalmol. Vis. Sci. 18:1979;437-446.
12. Ciulla T.A., Danis R.P., Harris A. Age-related macular degeneration: a review of experimental treatments. Surv. Ophthalmol. 43:1998;134-146.
13. Council, N.A.E., 1998. Vision Research - A National Plan: 1999-2003, Executive Summary. National Institutes of Health, Bethesda, MD.
14. Crabtree D., Snodderly D., Adler A. Retinyl palmitate in macaque retina-retinal pigment epithelium-choroid: distribution and correlation with age and vitamin E. Exp. Eye Res. 64:1997;455-463.
15. Curcio C.A., Millican C.L. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 117:1999;329-339.
16. Curcio C.A., Sloan K.R., Kalina R.E., Hendrickson A.E. Human photoreceptor topography. J. Comp. Neurol. 292:1990;497-523.
17. Curcio C.A., Millican C.L., Allen K.A., Kalina R.E. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest. Ophthalmol. Vis. Sci. 34:1993;3278-3296.
18. Curcio C.A., Medeiros N.E., Millican C.L. Photoreceptor loss in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 37:1996;1236-1249.
19. Curcio C.A., Medeiros N.E., Millican C.L. The Alabama age-related macular degeneration grading system for donor eyes. Invest. Ophthalmol. Vis. Sci. 39:1998;1085-1096.
20. Curcio C.A., Saunders P.L., Younger P.W., Malek G. Peripapillary chorioretinal atrophy: Bruch's membrane changes and photoreceptor loss. Ophthalmology. 107:2000;334-343.
21. Curcio, C.A., Bailey, T., Kruth, H.S., 2001a. Cholesterol content of basal deposits and drusen in eyes with age-related maculopathy (ARM): filipin histochemistry. Invest. Ophthalmol. Vis. Sci. 42 (abstract).
22. Curcio C.A., Millican C.L., Bailey T., Kruth H.S. Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42:2001b;265-274.
23. Delori F.C., Fleckner M.R., Goger D.G., Weiter J.J., Dorey C.K. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 41:2000;496-504.
24. Delori F.C., Goger D.G., Dorey C.K. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest. Ophthalmol. Vis. Sci. 42:2001;1855-1866.
25. Dowling J., Wald G. Vitamin A deficiency and night blindness. Proc. Natl. Acad. Sci. U.S.A. 44:1958;648-661.
26. Eldred, G.E., 1998. Lipofuscin and other lysosomal storage deposits in the retinal pigment epithelium. In: Marmor, M.F., Wolfensberger, T.J. (Eds.), The Retinal Pigment Epithelium: Function and Disease. Oxford University Press, New York, pp. 651-668.
27. Feeney-Burns L., Ellersieck M.R. Age-related changes in the ultrastructure of Bruch's membrane. Am. J. Ophthalmol. 100:1985;686-697.
28. Green W.R., Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman lecture. Ophthalmology. 100:1993;1519-1535.
29. Hageman G.S., Luthert P.J., Chong N.H.C., Johnson L.V., Anderson D.H., Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Ret. Eye Res. 20:2001;705-732.
30. Haig C., Hecht S., Patek A.J. Vitamin A and rod-cone adaptation in cirrhosis of the liver. Science. 87:1938;534.
31. Haimovici R., Gantz D.L., Rumelt S., Freddo T.F., Small D.M. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing microscopy. Invest. Ophthalmol. Vis. Sci. 42:2001;1592-1599.
32. Holz F.G., Schütt F., Kopitz J., Eldred G.E., Kruse F.E., Völcker H.E., Cantz M. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest. Ophthalmol. Vis. Sci. 40:1999;737-743.
33. Holz F., Bellman C., Staudt S., Schutt F., Volcker H. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42:2001;1051-1056.
34. Hussain A.A., Rowe L., Marshall J. Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. J. Opt. Soc. Am. A. 19:2002;166-172.
35. Jackson G.R., Owsley C. Scotopic sensitivity during adulthood. Vis. Res. 40:2000;2467-2473.
36. Jackson G.R., Owsley C., Cordle E.P., Finley C.D. Aging and scotopic sensitivity. Vis. Res. 38:1998;3655-3662.
37. Jackson G.R., Owsley C., McGwin G. Aging and dark adaptation. Vis. Res. 39:1999;3975-3982.
38. Jacobson S.G., Voigt W.J., Parel J.-M., Apathy P.P., Nghiem-Phu L., Myers S.W., Patella V.M. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 93:1986;1604-1611.
39. Jacobson S.G., Cideciyan A.V., Regunath G., Rodriguez F.J., Vandenburgh K., Sheffield V.C., Stone E.M. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat. Genet. 11:1995;27-32.
40. Karwatowski W., Jeffried T., Duance V., Albon J., Bailey A., Easty D. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. Br. J. Ophthalmol. 79:1995;944-952.
41. Katz M., Drea C., Robison W. Jr. Age-related alterations in vitamin A metabolism in the rat retina. Exp. Eye Res. 44:1987;939-949.
42. Katz M., Kutryb M., Norberg M., Gao C., White R., Stark W. Maintenance of opsin density in photoreceptor outer segments of retinoid-deprived rats. Invest. Ophthalmol. Vis. Sci. 32:1991;1968-1980.
43. Katz M., Gao C., Stientjes H. Regulation of the interphotoreceptor retinoid-binding protein content of the retina by vitamin A. Exp. Eye Res. 57:1993;393-401.
44. Kemp C., Jacobson S., Faulkner D., Walt R. Visual function and rhodopsin levels in humans with vitamin A deficiency. Exp. Eye Res. 46:1988;185-197.
45. Kemp C., Jacobson S., Borruat F., Chaitin M. Rhodopsin levels and retinal function in cats during recovery from vitamin A deficiency. Exp. Eye Res. 49:1989;49-65.
46. Kim R.Y., Faktorovich E.G., Kuo C.Y., Olson J.L. Retinal function abnormalities in membranoproliferative glomerulonephritis type II. Am. J. Ophthalmol. 123:1997;619-628.
47. Klein R., Davis M.D., Magli Y.L., Segal P., Klein B.E.K., Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 98:1991;1128-1134.
48. Klein R., Klein B.E.K., Linton K.L.P. Prevalence of age-related maculopathy. Ophthalmology. 99:1992;933-943.
49. Klein R., Wang Q., Klein B.E.K., Moss S.E., Meuer S.M. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest. Opthalmol. Vis. Sci. 36:1995;182-191.
50. Klein R., Klein B.E.K., Jensen S.C., Meuer S.M. The 5-year incidence and progression of age-related maculopathy. Ophthalmology. 104:1997;7-21.
51. Kosnik W., Winslow L., Kline D., Rasinski K., Sekuler R. Visual changes in daily life throughout adulthood. J. Gerontol. 43:1988;P63-P70.
52. Kuntz C.A., Jacobson S.G., Cideciyan A.V., Li Z.-Y., Stone E.M., Possin D., Milam A.H. Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. Invest. Ophthalmol. Vis. Sci. 37:1996;1772-1782.
53. Lamb T.D. Spontaneous quantal events induced in toad rods by pigment bleaching. Nature. 287:1980;349-351.
54. Lamb T.D. The involvement of rod photoreceptors in dark adaptation. Vis. Res. 21:1981;1773-1782.
55. Lamb T.D., Cideciyan A.V., Jacobson S.G., Pugh E.N. Towards a molecular description of human dark adaptation. J. Physiol. 506:1998;88.
56. LaVail M.M. Analysis of neurological mutants with inherited retinal degeneration. Invest. Ophthalmol. Vis. Sci. 21:1981;638-657.
57. Leibrock C.S., Reuter T., Lamb T.D. Molecular basis of dark adaptation in rod photoreceptors. Eye. 12:1998;511-520.
58. Li T., Sandberg M.A., Pawlyk B.S., Rosner B., Hayes K.C., Dryja T.P., Berson E.L. Effect of vitamin A supplementation on rhodopsin mutants threonine-17-methionine and proline-347-serine in transgenic mice and in cell cultures. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11933-11938.
59. Macular Photocoagulation Study Group, 1991. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch. Ophthalmol. 109, 1242-1257.
60. Marshall, J., Hussain, A.A., Starita, C., Moore, D.J., Patmore, A.L., 1998. Aging and Bruch's membrane. In: Marmor, M.F., Wolfensberger, T.J. (Eds.), The Retinal Pigment Epithelium: Function and Disease. Oxford University Press, New York, pp. 669-692.
61. Mata N., Tzekov R., Liu X., Weng J., Birch D., Travis G. Delayed dark-adaptation and lipofuscin accumulation in abcr ± mice: implications for involvement of ABCR in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42:2001;1685-1690.
62. McBee J.K., Palczewski K., Baehr W., Pepperberg D.R. Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog. Ret. Eye Res. 20:2001;469-529.
63. Medeiros N.E., Curcio C.A. Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42:2001;795-803.
64. Mitchell P., Smith W., Attebo K., Wang J.J. Prevalence of age-related maculopathy in Australia. The blue mountains eye study. Ophthalmology. 102:1995;1450-1460.
65. Mohand-Said S., Deudon-Combe A., Hicks D., Simonutti M., Forster V., Fintz A.C., Leveillard T., Dreyfus H., Sahel J.A. Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8357-8362.
66. Moore D.J., Clover G.M. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42:2001;2970-2975.
67. Moore D.J., Hussain A.A., Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 36:1995;1290-1297.
68. Owsley C., Jackson G.R., Cideciyan A.V., Huang Y., Fine S.L., Ho A.C., Maguire M.G., Lolley V., Jacobson S.G. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 41:2000;267-273.
69. Owsley C., Jackson G.R., White M., Feist R., Edwards D.J. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 108:2001;1196-1202.
70. Pauleikhoff D., Harper C.A., Marshall J., Bird A.C. Aging changes in Bruch's membrane: a histochemical and morphological study. Ophthalmology. 97:1990;171-178.
71. Redmond T.M., Yu S., Lee E., Bok D., Hamasaki D., Chen N., Goletz P., Ma J.X., Crouch R.K., Pfeifer K. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 20:1998;344-351.
72. Saari J.C. Biochemistry of visual pigment regeneration. The Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 41:2000;337-348.
73. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 60:1976;324-341.
74. Schutt F., Davies S., Kopitz J., Holz F., Boulton M. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest. Ophthalmol. Vis. Sci. 41:2000;2303-2308.
75. Scilley, K., Jackson, G.R., Cideciyan, A.V., Maguire, M.G., Jacobson, S.G., Owsley, C., 2002. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology, in press.
76. Seeliger M.W., Biesalski H.K., Wissinger B., Gollnick H., Gielen S., Frank J., Beck S., Zrenner E. Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest. Ophthalmol. Vis. Sci. 40:1999;3-11.
77. Seeliger M.W., Grimm C., Stahlberg F., Friedburg C., Jaissle G., Zrenner E., Guo H., Remé C.E., Humphries P., Hofmann F., Biel M., Fariss R.N., Redmond T.M., Wenzel A. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat. Genet. 29:2001;70-74.
78. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C.W., Klein B.E.K., Hofman A., Jensen S., Wang J.J., de Jong P.T.V.M. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology. 108:2001;697-704.
79. Snodderly D.M. Evidence for protection against age-related macular degeneration (AMD) by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 62(Suppl.):1995;1448S-1461S.
80. Spraul C.W., Grossniklaus H.E. Characteristics of drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch. Ophthalmol. 115:1997;267-273.
81. Starita C., Hussain A.A., Patmore A., Marshall J. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 38:1997;762-767.
82. Steinmetz R.L., Haimovici R., Jubb C., Fitzke F.W., Bird A.C. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br. J. Ophthalmol. 77:1993;549-554.
83. Stone E., Sheffield V., Hageman G. Molecular genetics of age-related macular degeneration. Hum. Mol. Genet. 10:2001;2285-2292.
84. Suter M., Reme C., Grimm C., Wenzel A., Jaattela M., Esser P., Kociok N.M.L., Richter C. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275:2000;39625-39630.
85. Van Hooser J.P., Aleman T.S., He Y.G., Cideciyan A.V., Kuksa V., Pittler S.J., Stone E.M., Jacobson S.G., Palczewski K. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8623-8628.
86. Vingerling J.R., Dielemans I., Hofman A., Grobbee D.E., Hijmering M., Kramer C.F.L., de Jong P.T.V.M. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology. 102:1995;205-210.
87. Wang Q., Chappell R.J., Klein R., Eisner A., Klein B.E.K., Jensen S.C., Moss S.E. Pattern of age-related maculopathy in the macular area. The Beaver Dam eye study. Invest. Ophthalmol. Vis. Sci. 37:1996;2234-2242.
88. Weeks D., Conley Y., Tsai H., Mah T., Rosenfeld P., Paul T., Eller A., Morse L., Dailey J., Ferrell R., Gorin M. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am. J. Ophthalmol. 132:2001;682-692.
89. Werner J.S., Donnelly S.K., Kliegl R. Aging and human macular pigment density. Vis. Res. 27:1987;257-268.